|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |||||||
| 化学式 | C29H25N3O4S |
||||||||||
| 分子量 | 511.59 | CAS No. | 846557-71-9 | ||||||||
| Solubility (25°C)* | 体外 | DMSO (warmed with 50ºC water bath) | 50 mg/mL (97.73 mM) | ||||||||
| Water | Insoluble | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | ML385 is a novel and specific NRF2 inhibitor with an IC50 of 1.9 μM. It inhibits the downstream target gene expression of NRF2. NRF2 regulates the activity of several ferroptosis and lipid peroxidation-related proteins. |
|---|---|
| in vitro | ML385 shows anti-tumor activity in NSCLC (subcutaneous and orthotopic NSCLC models) both as a single agent and in combination. The PK profile tested in CD-1 mice shows that this compound has a half-life (t1/2 = 2.82 h) after IP injection (30 mg/kg)[1]. This chemical could alleviate the pancreatic injury[2]. |
| 細胞アッセイ | 細胞株 | A549 cells |
|---|---|---|
| 濃度 | 5 μM | |
| 反応時間 | 24, 48 and 72 h | |
| 実験の流れ | -- |
|
| 動物実験 | 動物モデル | male CD-1 mice |
| 投薬量 | 30 mg/kg | |
| 投与方法 | i.p. |
|
| Sodium nitrate protects against metabolic syndrome by sialin-mediated macrophage rebalance [ Signal Transduct Target Ther, 2025, 10(1):323] | PubMed: 41034188 |
| Ferroptosis in acute liver Failure: Unraveling the hepcidin-ferroportin axis and therapeutic interventions [ Redox Biol, 2025, 84:103657] | PubMed: 40393152 |
| 5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma [ EMBO Mol Med, 2025, 10.1038/s44321-025-00293-5] | PubMed: 40897859 |
| Growth differentiation factor 15 aggravates sepsis-induced cognitive and memory impairments by promoting microglial inflammatory responses and phagocytosis [ J Neuroinflammation, 2025, 22(1):44] | PubMed: 39985040 |
| Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway [ Front Immunol, 2025, 16:1529176] | PubMed: 40083556 |
| SAMSN1 causes sepsis immunosuppression by inducing macrophages to express coinhibitory molecules that cause T-cell exhaustion via KEAP1-NRF2 signaling [ Chin Med J (Engl), 2025, 138(13):1607-1620] | PubMed: 40293473 |
| Oridonin mitigates bacterial pneumonia by regulating mitochondrial integrity and ferroptosis via targeting KEAP1/NRF2 signaling [ Biochem Pharmacol, 2025, 242(Pt 2):117310] | PubMed: 40925465 |
| Hyperoxia-activated Nrf2 regulates ferroptosis in intestinal epithelial cells and intervenes in inflammatory reaction through COX-2/PGE2/EP2 pathway [ Mol Med, 2025, 31(1):1] | PubMed: 39754066 |
| Ligustrazine hydrochloride Prevents Ferroptosis by Activating the NRF2 Signaling Pathway in a High-Altitude Cerebral Edema Rat Model [ Int J Mol Sci, 2025, 26(3)1110] | PubMed: 39940878 |
| Transcriptional Repression of CCL2 by KCa3.1 K+ Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M2 Macrophages [ Int J Mol Sci, 2025, 26(15)7624] | PubMed: 40806751 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。